(Q37617602)

21 August 2017

1 reference

title

Neuroblastoma: biology and staging (English)

1 reference

21 August 2017

1 reference

1

Sabine Mueller

1 reference

21 August 2017

Katherine K Matthay

2

1 reference

21 August 2017

1 November 2009

1 reference

21 August 2017

8

1 reference

inferred from page(s)

published in

Current Oncology Reports

1 reference

21 August 2017

11

1 reference

21 August 2017

431-438

1 reference

21 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-009-0059-6

21 August 2017

0 references

cites work

Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study

1 reference

12 December 2020

Chromosome 1p and 11q deletions and outcome in neuroblastoma

1 reference

12 December 2020

A population-based study of the usefulness of screening for neuroblastoma

1 reference

12 December 2020

High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene

1 reference

12 December 2020

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

1 reference

12 December 2020

Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).

1 reference

12 December 2020

Unholy matrimony: Aurora A and N-Myc as malignant partners in neuroblastoma.

1 reference

12 December 2020

Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee

1 reference

12 December 2020

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

12 December 2020

Oncogenic mutations of ALK kinase in neuroblastoma

1 reference

12 December 2020

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany

1 reference

12 December 2020

Molecular genetic analysis of familial neuroblastoma

1 reference

12 December 2020

Radiochemistry, biochemistry, and kinetics of 131I-metaiodobenzylguanidine (MIBG) and 123I-MIBG: clinical implications of the use of 123I-MIBG.

1 reference

12 December 2020

Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells

1 reference

12 December 2020

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

1 reference

12 December 2020

Neuroblastoma: a disease requiring a multitude of imaging studies.

1 reference

12 December 2020

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

1 reference

12 December 2020

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

1 reference

12 December 2020

Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.

1 reference

12 December 2020

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force

1 reference

12 December 2020

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study

1 reference

12 December 2020

Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients

1 reference

12 December 2020

Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide

1 reference

12 December 2020

Neuroblastoma in adults and adolescents: an indolent course with poor survival

1 reference

12 December 2020

Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts

1 reference

12 December 2020

Activating mutations in ALK provide a therapeutic target in neuroblastoma

1 reference

12 December 2020

Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.

1 reference

12 December 2020

Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma

1 reference

12 December 2020

Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study

1 reference

12 December 2020

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

1 reference

12 December 2020

Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study

1 reference

12 December 2020

Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma

1 reference

12 December 2020

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

1 reference

12 December 2020

Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.

1 reference

12 December 2020

Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study

1 reference

12 December 2020

Molecular biology of neuroblastoma

1 reference

12 December 2020

CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas

1 reference

12 December 2020

International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.

1 reference

12 December 2020

Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group

1 reference

12 December 2020

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report

1 reference

12 December 2020

Prenatally diagnosed neuroblastoma

1 reference

12 December 2020

Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial

1 reference

12 December 2020

Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience

1 reference

12 December 2020

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

1 reference

12 December 2020

CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23

1 reference

12 December 2020

Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma

1 reference

12 December 2020

Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma

1 reference

12 December 2020

Identification of ALK as a major familial neuroblastoma predisposition gene

1 reference

12 December 2020

Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma

1 reference

12 December 2020

10.1007/S11912-009-0059-6

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19840520